Panacea Biotec is an Indian pharmaceutical and biotechnology company headquartered in New Delhi. It is engaged in the research, development, manufacture and marketing of vaccines and pharmaceutical formulations, with a particular focus on paediatric vaccines, organ transplantation drugs and chronic disease therapies.
Key facts
| Type | Public company |
|---|---|
| Industry | Pharmaceuticals, vaccines, biotechnology |
| Headquarters | New Delhi, India |
| Country | India |
| Listings | BSE, NSE |
Background
Panacea Biotec operates as an integrated pharmaceutical company, combining in-house research and development with manufacturing capabilities. Its product portfolio spans human vaccines and branded pharmaceutical formulations across therapeutic areas such as transplantation, oncology, diabetes, pain management and osteoarthritis. Over the years, the company has positioned itself as one of India's prominent vaccine manufacturers, supplying products both within India and to international markets.
Vaccines
The company is recognised for its work on combination paediatric vaccines, including formulations against poliomyelitis, hepatitis B, diphtheria, pertussis, tetanus and Haemophilus influenzae type b. Panacea Biotec has been a supplier of vaccines to United Nations agencies for global immunisation programmes, including procurement by UNICEF for use in low- and middle-income countries.
Pharmaceutical formulations
In the pharmaceutical segment, Panacea Biotec markets branded formulations in India and several international markets. Its therapeutic emphasis includes immunosuppressants used after organ transplantation, where the company has established a presence among Indian transplant practitioners.
Operations
Panacea Biotec has manufacturing and research facilities in northern India, including sites associated with vaccine production and pharmaceutical formulation. The company invests in research and development for new vaccines and dosage forms, and it has pursued collaborations and licensing arrangements with international partners on vaccine technology and distribution.
Significance
As one of the Indian companies engaged in large-scale vaccine manufacturing, Panacea Biotec has played a role in expanding access to affordable immunisation in developing countries through multilateral procurement channels. Its work on combination vaccines has contributed to India's broader position as a major global vaccine producer.
Related topics
- Pharmaceutical industry in India
- Vaccine manufacturers in India
- UNICEF
- Universal Immunization Programme
- Biotechnology in India
References
- Wikidata: Q7129751